OBAGI C RX system C CLARIFYING SERUM
OBAGI-C RX SYSTEM
Approved
Approval ID
9ff4f617-b8d3-46d6-8ddb-41088dd8f226
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 24, 2019
Manufacturers
FDA
Obagi Cosmeceuticals LLC
DUNS: 790553353
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
HYDROQUINONE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code62032-106
Product Classification
G
Generic Name
HYDROQUINONE
Product Specifications
Route of AdministrationTOPICAL
Effective DateDecember 24, 2019
FDA Product Classification
INGREDIENTS (6)
HYDROQUINONEActive
Quantity: 40 mg in 1 mL
Code: XV74C1N1AE
Classification: ACTIB
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ASCORBIC ACIDInactive
Code: PQ6CK8PD0R
Classification: IACT
PROPYLENE CARBONATEInactive
Code: 8D08K3S51E
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT